Trials / Unknown
UnknownNCT02287857
Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 360 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Domestic Tenofovir Disoproxil Fumarate Tablets in Chinese patients with hepatitis B ,compared with Tenofovir Disoproxil Fumarate Tablets of Gilead.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Domestic Tenofovir Disoproxil Fumarate Tablets | 1 Domestic Tenofovir Disoproxil Fumarate Tablets and 1 blank Tenofovir Disoproxil Fumarate Tablets of Gilead |
| DRUG | Tenofovir Disoproxil Fumarate Tablets of Gilead | 1 blank Domestic Tenofovir Disoproxil Fumarate Tablets and 1Tenofovir Disoproxil Fumarate Tablets of Gilead |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2014-11-11
- Last updated
- 2019-03-19
Locations
15 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02287857. Inclusion in this directory is not an endorsement.